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論 文 内 容 要 旨 
Background and Aims 
The corticotropin-releasing hormone (CRH) is known to play an important role in colonic 
response to stress and mediates stress-induced physiological changes. We verified our 
hypothesis that administration of a specific corticotropin-releasing hormone receptor 1 
(CRH-R1) antagonist attenuates visceral sensitivity, anxiety-like behaviors, 
hypothalamic-pituitary–adrenal axis (HPA) activation, c-Fos and CRH expression in the 
paraventricular nucleus (PVN) and the amygdala caused by acute colorectal distention 
(CRD) in rats.   
Methods 
Rats were randomly assigned to three groups: control, vehicle + CRD, and CRH-R1 
antagonist CP-154,526 (CP) + CRD. A CRH-R1 antagonist (20mg/kg) or vehicle was injected 
intraperitoneally 30 min before CRD. The visceral sensitivity was quantified with 
visceromotor response (VMR) to CRD using an electromyogram (EMG). Anxiety-like 
behavior was evaluated using elevated plus maze (EPM). After 3 days of EPM, tonic CRD 
was loaded and plasma adrenocorticotropic hormone (ACTH) and serum corticosterone were 
measured. Expression of c-Fos, CRH, and CRH-R1 in the paraventricular nucleus (PVN) 
and the amygdala was detected with immunohistochemistry.  
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Results 
 During phasic CRD, VMR in CP + CRD group was significantly lower than that in vehicle + 
CRD group. During tonic CRD, VMR in CP + CRD group was also significantly lower than 
that in vehicle + CRD group. The number of entries into EPM open arms was significantly 
higher in CP + CRD group than in vehicle + CRD group. Plasma ACTH levels and serum 
corticosterone levels showed no difference between vehicle + CRD and CP + CRD groups. 
CRD significantly increased the numbers of c-Fos, CRH and CRH-R1 positive cells in the 
PVN compared with control. These responses were significantly suppressed after treatment 
with CRH-R1 antagonist. CRH-R1 antagonist also significantly reduced the numbers of 
c-Fos and CRH positive cells evoked by CRD in the amygdala. 
Conclusions 
Our results suggest that treatment with a specific CRH-R1 antagonist attenuates visceral 
sensitivity and anxiety-like behaviors caused by visceral nociception with suppression of 
CRH neurons in the PVN and the amygdala in rats. 
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